Arkolith/Insider Trading/ALDX/Form 4

Edelman Joseph

10% OwnerAldeyra Therapeutics, Inc. (ALDX) · full profile →Form 4 · filed Apr 8, 2024
Net Buying
Open-Market Buys
$834K
Open-Market Sells
$0
Net Open-Market Flow
$834K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 5, 2024Buy(P)38K$4.74$179K9.3M
Apr 4, 2024Buy(P)140K$4.67$655K9.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-24-008171) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML